肺癌血清肿瘤标志物研究进展被引量：2

下载PDF

导出

摘要肺癌是当前全世界发病率和死亡率最高的恶性肿瘤。大部分患者确诊时已为晚期，失去了最佳治疗时机。近年来，虽然不断有新型的化疗药物被发现，但是肺癌五年存活率没有明显的提高。不能早期发现和诊断肺癌是导致它疗效差及高死亡率的主要原因，故提高肺癌预后的关键是早期诊断。

作者郑华岳文涛朱允中

机构地区北京市结核病胸部肿瘤研究所细胞生物学研究室北京胸科医院肿瘤内科

出处《结核病与胸部肿瘤》 2009年第2期150-154,共5页 Tuberculosis and Thoracic Tumor

关键词肺癌预后血清肿瘤标志物早期诊断高死亡率恶性肿瘤治疗时机化疗药物发病率

同被引文献44

1李子明,陆舜,廖美琳.肿瘤的靶向治疗[J].国外医学（肿瘤学分册）,2005,32(12):905-909. 被引量：4
2陈亚利,张韫,宋诗雨.组氨酸标签蛋白或含组氨酸标签的融合蛋白的免疫学定量检测方法:中国,CN200810235706.0[P].2009-04-22.
3Folkman J.Tumor angiogenesis:therapeutic implications[J].N Engl J Med,1971,285(21):1182-1186.
4Folkman J.Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action[J].Exp Cell Res,2006,312(5):594-607.
5O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:an endogenons inhibitor of angiogenesis and tumor growth[J].Cell,1997,88(2):277-285.
6Ling Y,Yang Y,Lu N,et al.Endostar,a novel recombinant human endostatin,exertsantiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Fik-1 of endothelial cells[J].Biochem Biophys Res Commun,2007,361(1):79-84.
7Folkman J.Clinical applications of research on angiogenesis[J].N Engl J Med,1995,333:1757-1763.
8Wickstrom SA,Alitalo K,Keski-Oja J.Endostatin associates with integrin alpha5beta1 and caveolin-1,and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells[J].Cancer Res,2002,62:5580-5589.
9te Velde EA,Reijerkerk A,Brandsma D,et al.Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells[J].Br J Cancer,2005,92(4):729-735.
10Bergers G,Hanahan D.Modes of resistance to anti-angiogenic therapy[J].Nat Rev Cancer,2008,8:592-603.

结核病与胸部肿瘤

2009年第2期

内容加载中请稍等...